LFCR Earnings Date: Nov 3, 2026 (Estimated) — Lifecore Biomedical, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is LFCR's next earnings date?
Lifecore Biomedical, Inc. (LFCR) is expected to report earnings on Tuesday, November 3, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.30 on revenue of $25.6M.
How did LFCR do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Lifecore Biomedical, Inc. posted EPS of -$0.19 versus the -$0.19 estimate, an in-line result. Revenue was $34.2M against a $32.0M estimate. The stock's 1-day post-earnings move was +2.1%.
How much does LFCR stock move after earnings?
LFCR beat EPS estimates in 3 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 15.5% (up or down) in the day after earnings.
About Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.19 | -0.19 | +9.52% | $34.2M | ➖ Inline | +2.07% | +11.03% | +8.97% |
| 2026-05-06 | Q1 2026 | -0.28 | -0.43 | -53.57% | $23.2M | ❌ Miss | -3.88% | -11.63% | +12.21% |
| 2026-03-16 | Q4 2025 | — | -0.16 | — | $35.7M | — | -33.26% | -38.53% | -20.49% |
| 2025-04-03 | Q3 2025 | -0.15 | -0.28 | -86.67% | $35.2M | ❌ Miss | -22.32% | -16.08% | +3.08% |
| 2025-01-02 | Q2 2025 | -0.31 | -0.25 | +19.35% | $32.6M | ✅ Beat | +14.41% | -5.56% | -10.81% |
| 2024-10-04 | Q1 2025 | -0.46 | -0.53 | -15.22% | $24.7M | ❌ Miss | +14.35% | -4.68% | +24.87% |
| 2024-08-26 | Q4 2024 | -0.26 | -0.20 | +23.08% | $37.9M | ✅ Beat | -25.24% | -31.07% | -25.24% |
| 2024-08-09 | Q1 2024 | -0.26 | -0.41 | -57.69% | $24.5M | ✅ Beat | +8.38% | +14.77% | -3.39% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q3 FY23 · $10.6M total
| Segment | Share | Revenue | YoY | Q3 FY23 |
|---|---|---|---|---|
| SWITZERLAND | 64.2% | $6.8M | — | $6.8M |
| AUSTRALIA | 10.4% | $1.1M | — | $1.1M |
| IRELAND | 10.4% | $1.1M | — | $1.1M |
| CANADA | 6.6% | $700K | — | $700K |
| CZECHIA | 6.6% | $700K | — | $700K |
| All Other Countries | 1.9% | $200K | — | $200K |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.